DG
Healthcare & Life Sciences

Daisy Genomics

Daisy Genomics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.

Activeseed
seed
Stage
1
Investors

About Daisy Genomics

Based in the United States, Daisy Genomics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Daisy Genomics develops a long-read DNA sequencing platform that uses nanochannels and nanopores combined with surface-enhanced Raman spectroscopy to enable rapid, amplification-free sequencing of complete human genomes with epigenetic modification detection.

Explore Daisy Genomics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States